[시장보고서]세계의 SDS 폴리아크릴아미드 겔 전기영동 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2033년)

세계의 SDS 폴리아크릴아미드 겔 전기영동 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2033년)

SDS Poly Acrylamide Gel Electrophoresis Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

상품코드 : 1558992

리서치사 : Persistence Market Research

발행일 : 2024년 09월

페이지 정보 : 영문 212 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 6,987,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,204,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 11,883,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

Persistence Market Research는 세계 SDS 폴리아크릴아미드 겔 전기영동 시장에 대한 종합적인 보고서를 발표하고 시장 성장 촉진요인, 동향, 기회, 과제 등 주요 시장 역학을 상세하게 분석했습니다. 이 상세한 보고서는 시장 구조와 예측 기간 동안의 성장 가능성에 대해 밝혔습니다.

주요 인사이트

SDS 폴리아크릴아미드 겔 전기영동 시장 규모(2024년) : 5억 1,830만 달러
시장 예측치(2033년) : 8억 2,720만 달러
세계 시장 성장률(CAGR 2024-2033년) : 5.3%

SDS 폴리아크릴아미드 겔 전기영동 시장 - 보고 범위:

SDS 폴리아크릴아미드 겔 전기영동(SDS-PAGE)은 분자 생물학과 생화학에서 분자량을 기준으로 단백질을 분리하는 데 널리 사용되는 기술입니다. 이 기술은 단백질 정량, 확인, 특성 분석을 포함한 단백질 분석에 필수적입니다. 시장은 의약품 개발, 진단, 기초 연구 등 다양한 용도에서 단백질 연구 수요 증가가 견인하고 있습니다.

시장 성장 촉진요인:

SDS 폴리아크릴아미드 겔 전기영동 세계 시장 성장을 이끌고 있는 주요 요인은 몇 가지입니다. 맞춤형 의료에 대한 관심 증가와 만성 질환의 확산은 고급 단백질 분석 기술에 대한 수요를 촉진하고 있습니다. 바이오의약품산업의 확대와 단백질체학의 연구개발활동의 활성화가 시장의 성장에 기여하고 있습니다. 겔 제형의 개선 및 자동화 시스템과 같은 전기영동 시스템의 기술적 진보는 단백질 분석의 효율성과 정확성을 향상시키고 있습니다. 또한 학술기관 및 연구기관에서의 SDS-PAGE 채용 증가가 시장 확대를 뒷받침하고 있습니다.

시장 성장 억제요인:

SDS 폴리아크릴아미드 겔 전기영동 시장은 그 성장성에도 불구하고 여러 과제에 직면하고 있습니다. 첨단 전기 영동 장치 및 시약과 관련된 높은 비용은 소규모 연구소 및 연구 기관의 장벽이 될 수 있습니다. 또한 SDS-PAGE 기술의 복잡성과 숙련자의 필요성으로 인해 사용이 제한될 수 있습니다. 시장은 또한 질량분석과 웨스턴 블로팅과 같은 대체 단백질 분석법과의 경쟁에 직면하고 있으며, SDS-PAGE의 채용에 영향을 미칠 수 있습니다. 겔 성능의 편차나 재현성의 문제도 과제가 될 수 있습니다.

시장 기회:

SDS 폴리아크릴아미드 겔 전기영동 시장은 특히 고성능 단백질체학와 맞춤형 의료 수요가 증가함에 따라 큰 성장 기회를 제공합니다. 보다 빠르고 정밀한 시스템 개발과 같은 전기 영동 기술의 혁신은 새로운 성장의 길을 설명합니다. 바이오마커 탐색과 단백질체학별 의약품 개발 등 새로운 부문에서 SDS-PAGE의 응용 확대도 새로운 기회를 기재하고 있습니다. 전기영동 시스템 제조업체와 연구기관 간의 전략적 제휴는 시장 성장과 기술 발전을 촉진합니다. 또한 전기영동기술과 다른 분석방법과의 융합에 주목이 모여 있는 것도 시장 확대의 기회가 됩니다.

이 보고서에서 다루는 주요 질문

SDS 폴리아크릴아미드 겔 전기영동 세계 시장을 견인하는 주요 요인은?
SDS-PAGE 기술의 채용이 가장 진행되고 있는 산업과 지역은?
전기영동 시스템의 발전은 경쟁 구도에 어떤 영향을 미치는가?
SDS 폴리아크릴아미드 겔 전기영동시장에서 선도 진출기업은 누구이며 시장 포지션을 유지하기 위해 어떤 전략을 취하고 있는가?
SDS 폴리아크릴아미드 겔 전기영동 세계 시장에서의 새로운 동향과 장래성은?

소개/주요 조사 결과
최종 사용자별 시장 규모(100만 달러) 실적 분석, 2019-2023년
현재와 장래 시장 규모(100만 달러)의 분석과 예측, 최종 사용자별, 2024-2033년
- 임상조사
- 생명공학과 제약업계
- 정부기관
- 학술기관
최종 사용자별 시장의 매력 분석

제10장 지역별 세계 시장 분석

소개
지역별 시장 규모(100만 달러) 실적 분석, 2019-2023년
현재와 장래 시장 규모(100만 달러)의 지역별 분석과 예측, 2024-2033년
- 북미
- 라틴아메리카
- 유럽
- 남아시아
- 동아시아
- 오세아니아
- 중동 및 아프리카
지역별 시장의 매력 분석

제11장 북미 시장 분석

제12장 라틴아메리카 시장 분석

제13장 유럽 시장 분석

제14장 남아시아 시장 분석

제15장 동아시아 시장 분석

제16장 오세아니아 시장 분석

제17장 중동 및 아프리카 시장 분석

제18장 시장 구조 분석

기업 Tier별 시장 분석
주요 기업의 시장 점유율 분석
시장현재분석

제19장 경쟁 분석

경쟁 대시보드
경쟁 벤치마킹
경쟁의 상세
- Bio-Rad Laboratories, Inc.
- General Electric Company(GE Healthcare)
- Merck KGaA(Sigma Aldrich)
- Thermos Fisher Scientific Inc.
- Analytik Jena Ag
- Lonza Group Ltd.
- Genscript Biotech Corporation
- Abcam Plc
- Takara Bio Inc.
- Amerigo Scientific
- Promega
- Cleaver Scientific Ltd.

제20장 사용된 전제조건과 약어

제21장 조사 방법

JHS

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global SDS Poly Acrylamide Gel Electrophoresis Market, providing an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges. This detailed report sheds light on the market structure and growth potential over the forecast period.

Key Insights:

SDS Poly Acrylamide Gel Electrophoresis Market Size (2024E): USD 518.3 Mn
Projected Market Value (2033F): USD 827.2 Mn
Global Market Growth Rate (CAGR 2024 to 2033): 5.3%

SDS Poly Acrylamide Gel Electrophoresis Market - Report Scope:

SDS Poly Acrylamide Gel Electrophoresis (SDS-PAGE) is a widely used technique in molecular biology and biochemistry for separating proteins based on their molecular weight. This technique is crucial for protein analysis, including protein quantification, identification, and characterization. The market is driven by the increasing demand for protein research in various applications, including drug development, diagnostics, and basic research.

Market Growth Drivers:

Several key factors are driving the growth of the global SDS Poly Acrylamide Gel Electrophoresis Market. The increasing focus on personalized medicine and the growing prevalence of chronic diseases are fueling demand for advanced protein analysis techniques. The expanding biopharmaceutical industry, coupled with rising research and development activities in proteomics, is contributing to market growth. Technological advancements in electrophoresis systems, such as improved gel formulations and automated systems, are enhancing the efficiency and accuracy of protein analysis. Additionally, the increasing adoption of SDS-PAGE in academic and research institutions is supporting market expansion.

Market Restraints:

Despite its growth potential, the SDS Poly Acrylamide Gel Electrophoresis Market faces several challenges. High costs associated with advanced electrophoresis equipment and reagents can be a barrier for smaller laboratories and research institutions. Additionally, the complexity of SDS-PAGE techniques and the requirement for skilled personnel may limit its accessibility. The market also faces competition from alternative protein analysis methods, such as mass spectrometry and western blotting, which may impact the adoption of SDS-PAGE. Variability in gel performance and reproducibility issues can also pose challenges.

Market Opportunities:

The SDS Poly Acrylamide Gel Electrophoresis Market presents substantial growth opportunities, particularly with the increasing demand for high-throughput proteomics and personalized medicine. Innovations in electrophoresis technologies, including the development of faster and more accurate systems, offer new growth avenues. Expanding applications of SDS-PAGE in emerging fields such as biomarker discovery and proteomics-based drug development provide additional opportunities. Strategic collaborations between electrophoresis system manufacturers and research institutions can drive market growth and technological advancements. The growing focus on integrating electrophoresis techniques with other analytical methods also presents opportunities for market expansion.

Key Questions Answered in the Report:

What are the primary factors driving the global SDS Poly Acrylamide Gel Electrophoresis Market?
Which industries and regions are witnessing the highest adoption of SDS-PAGE technology?
How are advancements in electrophoresis systems impacting the competitive landscape?
Who are the leading players in the SDS Poly Acrylamide Gel Electrophoresis Market, and what strategies are they implementing to maintain their market positions?
What are the emerging trends and future prospects in the global SDS Poly Acrylamide Gel Electrophoresis Market?

Competitive Intelligence and Business Strategy:

Leading players in the SDS Poly Acrylamide Gel Electrophoresis Market, including companies like Bio-Rad Laboratories, Thermo Fisher Scientific, GE Healthcare, Sigma-Aldrich, and Agilent Technologies, are focusing on innovation, research and development, and strategic partnerships to strengthen their market positions. These companies are investing in the development of advanced electrophoresis technologies, enhancing product performance, and expanding their product portfolios. Collaborations with research institutions and investment in new applications of SDS-PAGE are crucial for market penetration and sustained growth. Ensuring compliance with industry standards and regulations, as well as adapting to evolving research needs, helps these companies maintain a competitive edge and achieve long-term success in the SDS Poly Acrylamide Gel Electrophoresis Market.

Key Companies Profiled:

Bio-Rad Laboratories, Inc.
General Electric Company (GE Healthcare)
Merck KGaA (Sigma Aldrich)
Thermos Fisher Scientific Inc.
Analytik Jena Ag
Lonza Group Ltd.
Genscript Biotech Corporation
Abcam Plc
Takara Bio Inc.
Amerigo Scientific
Promega
Cleaver Scientific Ltd.

Key Segments Covered in SDS Poly Acrylamide Gel Electrophoresis Industry Research

Product:

Instruments
Reagents
Gels

End User:

Clinical Research
Biotechnology and Pharmaceutical Industry
Government Agencies
Academic Institutes

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
4.3. Recent Product Approval and Launches
4.4. PESTLE Analysis
4.5. Porter's Analysis
4.6. Regulatory Landscape
4.7. Value Chain Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Expenditure Outlook
- 5.1.3. Global Electrophoresis Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Growth of The Top Companies
- 5.2.2. Rise in The Protein Quantification Research Projects
- 5.2.3. Increasing Government Financing and Investment in The Biotech Sector
- 5.2.4. Research & Development Activities
- 5.2.5. Increase in Biopharmaceutical Businesses
- 5.2.6. Mergers and Acquisitions
- 5.2.7. Growing Adoption of SDS PAGE Products
5.3. Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Product
- 6.1.2. By End User
- 6.1.3. By Region
6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn ) Analysis 2019-2023 and Forecast, 2024-2033

7.1. Historical Market Value (US$ Mn ) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Mn ) Projections, 2024-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn ) Analysis By Product, 2019-2023
8.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Product, 2024-2033
- 8.3.1. Instruments
- 8.3.2. Reagents
- 8.3.3. Gels
  - 8.3.3.1. Handcast Gels
  - 8.3.3.2. Precast Gels
8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn ) Analysis By End User, 2019-2023
9.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By End User, 2024-2033
- 9.3.1. Clinical Research
- 9.3.2. Biotechnology and Pharmaceutical Industry
- 9.3.3. Government Agencies
- 9.3.4. Academic Institutes
9.4. Market Attractiveness Analysis By End User

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

10.1. Introduction
10.2. Historical Market Size (US$ Mn ) Analysis By Region, 2019-2023
10.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Region, 2024-2033
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. South Asia
- 10.3.5. East Asia
- 10.3.6. Oceania
- 10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2019-2023 and Forecast 2024-2033

11.1. Introduction
11.2. Historical Market Size (US$ Mn ) Analysis By Market Taxonomy, 2019-2023
11.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Market Taxonomy, 2024-2033
- 11.3.1. By Country
  - 11.3.1.1. U.S.
  - 11.3.1.2. Canada
- 11.3.2. By Product
- 11.3.3. By End User
11.4. Market Attractiveness Analysis
- 11.4.1. By Country
- 11.4.2. By Product
- 11.4.3. By End User
11.5. Country Level Analysis & Forecast
- 11.5.1. U.S. Market Analysis
  - 11.5.1.1. Introduction
  - 11.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 11.5.1.2.1. By Product
    - 11.5.1.2.2. By End User
- 11.5.2. Canada Market Analysis
  - 11.5.2.1. Introduction
  - 11.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 11.5.2.2.1. By Product
    - 11.5.2.2.2. By End User
11.6. Market Trends
11.7. Key Market Participants - Intensity Mapping
11.8. Drivers and Restraints - Impact Analysis

12. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

12.1. Introduction
12.2. Historical Market Size (US$ Mn ) Analysis By Market Taxonomy, 2019-2023
12.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Market Taxonomy, 2024-2033
- 12.3.1. By Country
  - 12.3.1.1. Brazil
  - 12.3.1.2. Mexico
  - 12.3.1.3. Argentina
  - 12.3.1.4. Rest of Latin America
- 12.3.2. By Product
- 12.3.3. By End User
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Product
- 12.4.3. By End User
12.5. Country Level Analysis & Forecast
- 12.5.1. Brazil Market Analysis
  - 12.5.1.1. Introduction
  - 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 12.5.1.2.1. By Product
    - 12.5.1.2.2. By End User
- 12.5.2. Mexico Market Analysis
  - 12.5.2.1. Introduction
  - 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 12.5.2.2.1. By Product
    - 12.5.2.2.2. By End User
- 12.5.3. Argentina Market Analysis
  - 12.5.3.1. Introduction
  - 12.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 12.5.3.2.1. By Product
    - 12.5.3.2.2. By End User
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis

13. Europe Market Analysis 2019-2023 and Forecast 2024-2033

13.1. Introduction
13.2. Historical Market Size (US$ Mn ) Analysis By Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast, By Market Taxonomy, 2024-2033
- 13.3.1. By Country
  - 13.3.1.1. Germany
  - 13.3.1.2. France
  - 13.3.1.3. Italy
  - 13.3.1.4. U.K.
  - 13.3.1.5. Spain
  - 13.3.1.6. Russia
  - 13.3.1.7. BENELUX
  - 13.3.1.8. Nordic Countries
  - 13.3.1.9. Rest of Europe
- 13.3.2. By Product
- 13.3.3. By End User
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Product
- 13.4.3. By End User
13.5. Country Level Analysis & Forecast
- 13.5.1. Germany Market Analysis
  - 13.5.1.1. Introduction
  - 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.1.2.1. By Product
    - 13.5.1.2.2. By End User
- 13.5.2. France Market Analysis
  - 13.5.2.1. Introduction
  - 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.2.2.1. By Product
    - 13.5.2.2.2. By End User
- 13.5.3. Italy Market Analysis
  - 13.5.3.1. Introduction
  - 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.3.2.1. By Product
    - 13.5.3.2.2. By End User
- 13.5.4. U.K. Market Analysis
  - 13.5.4.1. Introduction
  - 13.5.4.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.4.2.1. By Product
    - 13.5.4.2.2. By End User
- 13.5.5. Spain Market Analysis
  - 13.5.5.1. Introduction
  - 13.5.5.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.5.2.1. By Product
    - 13.5.5.2.2. By End User
- 13.5.6. Russia Market Analysis
  - 13.5.6.1. Introduction
  - 13.5.6.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.6.2.1. By Product
    - 13.5.6.2.2. By End User
- 13.5.7. Nordic Countries Market Analysis
  - 13.5.7.1. Introduction
  - 13.5.7.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.7.2.1. By Product
    - 13.5.7.2.2. By End User
- 13.5.8. BENELUX Market Analysis
  - 13.5.8.1. Introduction
  - 13.5.8.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.8.2.1. By Product
    - 13.5.8.2.2. By End User
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis

14. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Historical Market Size (US$ Mn ) Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Market Taxonomy, 2024-2033
- 14.3.1. By Country
  - 14.3.1.1. India
  - 14.3.1.2. Thailand
  - 14.3.1.3. Indonesia
  - 14.3.1.4. Malaysia
  - 14.3.1.5. Rest of South Asia
- 14.3.2. By Product
- 14.3.3. By End User
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product
- 14.4.3. By End User
14.5. Country Level Analysis & Forecast
- 14.5.1. India Market Analysis
  - 14.5.1.1. Introduction
  - 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.1.2.1. By Product
    - 14.5.1.2.2. By End User
- 14.5.2. Thailand Market Analysis
  - 14.5.2.1. Introduction
  - 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.2.2.1. By Product
    - 14.5.2.2.2. By End User
- 14.5.3. Indonesia Market Analysis
  - 14.5.3.1. Introduction
  - 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.3.2.1. By Product
    - 14.5.3.2.2. By End User
- 14.5.4. Malaysia Market Analysis
  - 14.5.4.1. Introduction
  - 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.4.2.1. By Product
    - 14.5.4.2.2. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Historical Market Size (US$ Mn ) Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Market Taxonomy, 2024-2033
- 15.3.1. By Country
  - 15.3.1.1. China
  - 15.3.1.2. Japan
  - 15.3.1.3. South Korea
- 15.3.2. By Product
- 15.3.3. By End User
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Product
- 15.4.3. By End User
15.5. Country Level Analysis & Forecast
- 15.5.1. China Market Analysis
  - 15.5.1.1. Introduction
  - 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.1.2.1. By Product
    - 15.5.1.2.2. By End User
- 15.5.2. Japan Market Analysis
  - 15.5.2.1. Introduction
  - 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.2.2.1. By Product
    - 15.5.2.2.2. By End User
- 15.5.3. South Korea Market Analysis
  - 15.5.3.1. Introduction
  - 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.3.2.1. By Product
    - 15.5.3.2.2. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis

16. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Historical Market Size (US$ Mn ) Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Market Taxonomy, 2024-2033
- 16.3.1. By Country
  - 16.3.1.1. Australia
  - 16.3.1.2. New Zealand
- 16.3.2. By Product
- 16.3.3. By End User
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product
- 16.4.3. By End User
16.5. Country Level Analysis & Forecast
- 16.5.1. Australia Market Analysis
  - 16.5.1.1. Introduction
  - 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.5.1.2.1. By Product
    - 16.5.1.2.2. By End User
- 16.5.2. New Zealand Market Analysis
  - 16.5.2.1. Introduction
  - 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.5.2.2.1. By Product
    - 16.5.2.2.2. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

17.1. Introduction
17.2. Historical Market Size (US$ Mn ) Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Market Taxonomy, 2024-2033
- 17.3.1. By Country
  - 17.3.1.1. GCC Countries
  - 17.3.1.2. Turkiye
  - 17.3.1.3. Northern Africa
  - 17.3.1.4. South Africa
  - 17.3.1.5. Rest of Middle East and Africa
- 17.3.2. By Product
- 17.3.3. By End User
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product
- 17.4.3. By End User
17.5. Country Level Analysis & Forecast
- 17.5.1. GCC Countries Market Analysis
  - 17.5.1.1. Introduction
  - 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.1.2.1. By Product
    - 17.5.1.2.2. By End User
- 17.5.2. Turkiye Market Analysis
  - 17.5.2.1. Introduction
  - 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.2.2.1. By Product
    - 17.5.2.2.2. By End User
- 17.5.3. Northern Africa Market Analysis
  - 17.5.3.1. Introduction
  - 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.3.2.1. By Product
    - 17.5.3.2.2. By End User
- 17.5.4. South Africa Market Analysis
  - 17.5.4.1. Introduction
  - 17.5.4.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.4.2.1. By Product
    - 17.5.4.2.2. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis

18. Market Structure Analysis

18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis

19. Competition Analysis

19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
- 19.3.1. Bio-Rad Laboratories, Inc.
  - 19.3.1.1. Overview
  - 19.3.1.2. Product Portfolio
  - 19.3.1.3. Key Financials
  - 19.3.1.4. Sales Footprint
  - 19.3.1.5. SWOT Analysis
  - 19.3.1.6. Strategy Overview
    - 19.3.1.6.1. Marketing Strategy
    - 19.3.1.6.2. Product Strategy
    - 19.3.1.6.3. Channel Strategy
- 19.3.2. General Electric Company (GE Healthcare)
  - 19.3.2.1. Overview
  - 19.3.2.2. Product Portfolio
  - 19.3.2.3. Key Financials
  - 19.3.2.4. Sales Footprint
  - 19.3.2.5. SWOT Analysis
  - 19.3.2.6. Strategy Overview
    - 19.3.2.6.1. Marketing Strategy
    - 19.3.2.6.2. Product Strategy
    - 19.3.2.6.3. Channel Strategy
- 19.3.3. Merck KGaA (Sigma Aldrich)
  - 19.3.3.1. Overview
  - 19.3.3.2. Product Portfolio
  - 19.3.3.3. Key Financials
  - 19.3.3.4. Sales Footprint
  - 19.3.3.5. SWOT Analysis
  - 19.3.3.6. Strategy Overview
    - 19.3.3.6.1. Marketing Strategy
    - 19.3.3.6.2. Product Strategy
    - 19.3.3.6.3. Channel Strategy
- 19.3.4. Thermos Fisher Scientific Inc.
  - 19.3.4.1. Overview
  - 19.3.4.2. Product Portfolio
  - 19.3.4.3. Key Financials
  - 19.3.4.4. Sales Footprint
  - 19.3.4.5. SWOT Analysis
  - 19.3.4.6. Strategy Overview
    - 19.3.4.6.1. Marketing Strategy
    - 19.3.4.6.2. Product Strategy
    - 19.3.4.6.3. Channel Strategy
- 19.3.5. Analytik Jena Ag
  - 19.3.5.1. Overview
  - 19.3.5.2. Product Portfolio
  - 19.3.5.3. Key Financials
  - 19.3.5.4. Sales Footprint
  - 19.3.5.5. SWOT Analysis
  - 19.3.5.6. Strategy Overview
    - 19.3.5.6.1. Marketing Strategy
    - 19.3.5.6.2. Product Strategy
    - 19.3.5.6.3. Channel Strategy
- 19.3.6. Lonza Group Ltd.
  - 19.3.6.1. Overview
  - 19.3.6.2. Product Portfolio
  - 19.3.6.3. Key Financials
  - 19.3.6.4. Sales Footprint
  - 19.3.6.5. SWOT Analysis
  - 19.3.6.6. Strategy Overview
    - 19.3.6.6.1. Marketing Strategy
    - 19.3.6.6.2. Product Strategy
    - 19.3.6.6.3. Channel Strategy
- 19.3.7. Genscript Biotech Corporation
  - 19.3.7.1. Overview
  - 19.3.7.2. Product Portfolio
  - 19.3.7.3. Key Financials
  - 19.3.7.4. Sales Footprint
  - 19.3.7.5. SWOT Analysis
  - 19.3.7.6. Strategy Overview
    - 19.3.7.6.1. Marketing Strategy
    - 19.3.7.6.2. Product Strategy
    - 19.3.7.6.3. Channel Strategy
- 19.3.8. Abcam Plc
  - 19.3.8.1. Overview
  - 19.3.8.2. Product Portfolio
  - 19.3.8.3. Key Financials
  - 19.3.8.4. Sales Footprint
  - 19.3.8.5. SWOT Analysis
  - 19.3.8.6. Strategy Overview
    - 19.3.8.6.1. Marketing Strategy
    - 19.3.8.6.2. Product Strategy
    - 19.3.8.6.3. Channel Strategy
- 19.3.9. Takara Bio Inc.
  - 19.3.9.1. Overview
  - 19.3.9.2. Product Portfolio
  - 19.3.9.3. Key Financials
  - 19.3.9.4. Sales Footprint
  - 19.3.9.5. SWOT Analysis
  - 19.3.9.6. Strategy Overview
    - 19.3.9.6.1. Marketing Strategy
    - 19.3.9.6.2. Product Strategy
    - 19.3.9.6.3. Channel Strategy
- 19.3.10. Amerigo Scientific
  - 19.3.10.1. Overview
  - 19.3.10.2. Product Portfolio
  - 19.3.10.3. Key Financials
  - 19.3.10.4. Sales Footprint
  - 19.3.10.5. SWOT Analysis
  - 19.3.10.6. Strategy Overview
    - 19.3.10.6.1. Marketing Strategy
    - 19.3.10.6.2. Product Strategy
    - 19.3.10.6.3. Channel Strategy
- 19.3.11. Promega
  - 19.3.11.1. Overview
  - 19.3.11.2. Product Portfolio
  - 19.3.11.3. Key Financials
  - 19.3.11.4. Sales Footprint
  - 19.3.11.5. SWOT Analysis
  - 19.3.11.6. Strategy Overview
    - 19.3.11.6.1. Marketing Strategy
    - 19.3.11.6.2. Product Strategy
    - 19.3.11.6.3. Channel Strategy
- 19.3.12. Cleaver Scientific Ltd.
  - 19.3.12.1. Overview
  - 19.3.12.2. Product Portfolio
  - 19.3.12.3. Key Financials
  - 19.3.12.4. Sales Footprint
  - 19.3.12.5. SWOT Analysis
  - 19.3.12.6. Strategy Overview
    - 19.3.12.6.1. Marketing Strategy
    - 19.3.12.6.2. Product Strategy
    - 19.3.12.6.3. Channel Strategy